The Hyderabad based pharmaceutical company said that in the initial weeks, it will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India.
https://ift.tt/eA8V8J from https://ift.tt/2U5938z
ليست هناك تعليقات:
إرسال تعليق